U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C16H22N6O2
Molecular Weight 330.3849
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide

SMILES

C[C@@H]1CCN(C[C@@H]1N(C)C2=C3C=CNC3=NC=N2)C(=O)CC(N)=O

InChI

InChIKey=CRDMXSMPTHMXRD-PWSUYJOCSA-N
InChI=1S/C16H22N6O2/c1-10-4-6-22(14(24)7-13(17)23)8-12(10)21(2)16-11-3-5-18-15(11)19-9-20-16/h3,5,9-10,12H,4,6-8H2,1-2H3,(H2,17,23)(H,18,19,20)/t10-,12+/m1/s1

HIDE SMILES / InChI

Approval Year

Name Type Language
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide
Systematic Name English
1-Piperidinepropanamide, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)-
Systematic Name English
(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanamide
Systematic Name English
Tofacitinib impurity L
Common Name English
Code System Code Type Description
PUBCHEM
78358280
Created by admin on Sat Dec 16 19:57:08 GMT 2023 , Edited by admin on Sat Dec 16 19:57:08 GMT 2023
PRIMARY
CAS
1675248-19-7
Created by admin on Sat Dec 16 19:57:08 GMT 2023 , Edited by admin on Sat Dec 16 19:57:08 GMT 2023
PRIMARY
FDA UNII
PT8DR2MS4E
Created by admin on Sat Dec 16 19:57:08 GMT 2023 , Edited by admin on Sat Dec 16 19:57:08 GMT 2023
PRIMARY